Investigación / Grupos de investigación

Grupo  602

Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Publicaciones (919)

  • Valero, V; Forbes, J; Pegram, MD; Pienkowski, T; Eiermann, W; von Minckwitz, G; Roche, H; Martin, M; Crown, J; Mackey, JR; Fumoleau, P; Rolski, J; Mrsic-Krmpotic, Z; Jagiello-Gruszfeld, A; Riva, A; Buyse, M; Taupin, H; Sauter, G; Press, MF; Slamon, DJ.

    Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens

    JOURNAL OF CLINICAL ONCOLOGY. 2011; 29(2): 149-156 Nº de citas: 217 [doi:10.1200/JCO.2010.28.6450]